Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve Unaudited Financial Results for ....
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, 07 November 2025 at the registered office in Mumbai. The main agenda item is to consider and approve the Unaudited Financial Results for the quarter and half year ended 30 September 2025 (i.e., Q2 FY26 and H1 FY26 results). The trading window for designated persons and their immediate relatives has been closed since 01 October 2025 and will remain shut until 48 hours after the results are declared, ending on 09 November 2025. This is a routine regulatory intimation under SEBI's Listing Regulations and does not contain any actual financial numbers.
No direct impact on the stock from this filing alone — it is a standard advance notice. Investors should watch for the actual Q2/H1 FY26 results on or after 07 November 2025 for meaningful insights into the company's earnings performance.